Clare McLean Family physician Alisa Hideg is checked by a UW Medical Center nurse after receiving her shots in a UW tumor vaccine trial. Hideg was diagnosed with an aggressive form of breast cancer in 2011.
Posted under: Health and Medicine , Research , Science , Technology , Uncategorized , UW and the Community. In June 2011 Dr. Alisa Hideg was a 42-year-old mother and family physician in the prime of her career practicing at Group Health in Spokane when she was diagnosed with estrogen and progesterone receptor negative/HER 2 positive breast cancer. Breast cancer in young, premenopausal women is usually aggressive. So even after chemotherapy, a double mastectomy, and radiation, with her cancer in remission, Hideg wasn't ready to take it easy. Both the type of breast cancer and the fact that it happened at a young age made her chances of relapse higher. This knowledge led her to experimental trials, and to the UW's Tumor Vaccine Group. Hideg found the UW Tumor Vaccine Group on the NIH's clinical trials website, ClinicalTrials.gov.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
